A Randomized, Double-Blind, Placebo-Controlled, Parallel

Project: Research project

Description

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Study of the Safety and Efficacy of ABT-126 in the Treatment of Cognitive Deficits in Schizophrenia(CDS)
StatusFinished
Effective start/end date11/1/1010/30/11

Funding

  • Abbott Laboratories

Fingerprint

Schizophrenia
Placebos
Safety
Therapeutics